<!DOCTYPE html>
<html lang="en">

<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="stylesheet" href="style.css">
  <title>Document</title>
</head>

<body>
  <div class="container">
  <header>
    <img class="logo" src="images/210331_23472_eMail_EADO_FollowUp.png" alt="">
    <img class="melanoma" src="images/Image2.png" alt="">
  </header>
    <div class="doctor">
      <h1>Dear Doctor [Name]</h1>
      <p class="for-doctor">
        We are proud to share with you the latest insights from
        <span class="red-text">Eucerin satellite symposium</span> held <br>
        during the 10th World Congress of Melanoma in conjunction with the 17th
        EADO Congress
      </p>
    </div>
    <h2>ACT IN CONTROL</h2>
    <p class="prevention">PREVENTION, TREATMENT AND FOLLOW-UP OF ACTINIC KERATOSIS <br> AND NMSC IN TIMES OF PANDEMIC
    </p>
    <div class="yellow-line"></div>
    <div class="doctor-container">
      <div class="doctor1">
        <img  src="images/doctor1.png" alt="">
        <div>
          <p class="diagnosis">
            Actinic keratosis diagnosis and treatment: <br>
            <b>What´s New</b>
          </p>
          <p class="yellow-text">Prof. Dr. Eggert Stockfleth</p>
          <p class="information">
            Skin Cancer Center, Department of Dermatology, <br>
            Ruhr-University Bochum, Germany
          </p>
        </div>
      </div>
      <div class="doctor2">
        <img src="images/doctor2.png" alt="">
        <div>
          <p class="diagnosis">
            Can you feel it? Discover Eucerin <sub>®</sub>´s <br> 1st medical device <br>
            ACTINIC CONTROLMD SPF 100 for <br> prevention and adjunctive treatment <br>
            of actinic keratosis
          </p>
          <p class="yellow-text">Dr. Julia Gallinger</p>
          <p class="information">Eucerin <sub>®</sub>Global Medical Management, <br> 
            Hamburg, Germany
          </p>
        </div>
      </div>
      <div class="doctor3">
        <img src="images/doctor3.png" alt="">
        <div>
          <p class="diagnosis">
            AK on the RADAR: <br> Risk management - Active surveillance <br> - Digital follow-up - Adherence to <br> prevention - Rapidity and simplification
          </p>
          <p class="yellow-text">Prof. Dr. Giuseppe Argenziano</p>
          <p class="information">
            Dermatology Unit, University of Campania Luigi <br> Vanvitelli, Naples, Italy</p>
        </div>
      </div>
      <div class="doctor4">
        <img src="images/doctor4.png" alt="">
        <div>
          <p class="diagnosis">
            Chairwoman of Symposium & <br>
            Congress President of EADO :
          </p>
          <p class="yellow-text">Prof. Dr. Ketty Peris</p>
          <p class="information">
            Institute of Dermatology, Università Cattolica - <br> Fondazione Policlinico Universitario A. Gemelli, <br> IRCCS, Rome, Italy
          </p>
        </div>
        </div>
      </div>
      <div class="watch-now">
        <a href="">WATCH NOW</a>
      </div>
      <div class="eukerit-virtual-booth">
        <p>Recorded symposium will be available on our Eucerin virtual booth <br>
          until 15th of May on our Eucerin virtual booth
        </p>
      </div>
      <div class="medical-team">
        <p>Additional medical information will be gladly provided by Your Medical Detailer.</p>
        <p class="questions">Please reach out to us if you have any questions. <br>
         <b>Eucerin Medical Team</b> 
        </p>
        <a href="#"><img src="images/logo1.png" alt=""></a>
        <a href="#"><img src="images/logo2.png" alt=""></a>
        <a href="#"><img src="images/logo3.png" alt=""></a>
      </div>
      <div class="dermatologikal">
        <img src="images/210331_23472_eMail_EADO_FollowUp.png" alt="">
        <p>WE BELIEVE IN THE LIFE-CHANGING POWER OF DERMATOLOGICAL SKINCARE</p>
      </div>
      <footer>
        <div class="inform">
          <p class="website">This is a newsletter from Beiersdorf AG Corporate Communications, Unnastraße 48, 20245 Hamburg, Germany, Tel: +49 (0) 40 - 49090, Fax: +49 (0) 40 - 4909 3434. <br>
            Electronic contact. Info: Please visit our corporate site for company related questions, such as: investor relations, jobs and press. <br>
            Website: <a class="red-text" href="">www.Beiersdorf.com</a>  
          </p>
          <p class="subscribed">You have subscribed to the Eucerin Medical News letter from www.eucerin.de. If you no longer wish to receive this newsletter in the future, <a class="red-text" href="#">please click here.</a></p>
          <p class="register">Representatives: Stefan De Loecker (Vorstandsvorsitzender), Astrid Hermann, Thomas Ingelfinger, Zhengrong Liu, Ramon A. Mirt, Asim Naseer, Dessi Temperley, <br> Vincent Warnery. Contact details as above. Chairman of the Supervisory Board: Prof. Dr. Reinhard Pöllath. Commercial Register / Reg. No.: Commercial Register <br> Hamburg, HRB 1787. VAT Identification No.: DE 118 513 961. Edited by: <a class="red-text" href="">onlinerelations@beiersdorf.com</a></p>
        </div>
      </footer>
    </div>
</body>
</html>